AB Corporate Bond ETF (NASDAQ:EYEG) Stock Short Interest Drops 89.5%

AB Corporate Bond ETF (NASDAQ:EYEG) saw a large drop in short interest during the month of September. As of September 15th, there was short interest totaling 109 shares, a drop of 89.5% from the August 31st total of 1,040 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 461 shares, the days-to-cover ratio is currently 0.2 days.

AB Corporate Bond ETF Trading Down 0.3%

Shares of EYEG traded down $0.12 on Thursday, reaching $33.70. 316 shares of the company’s stock were exchanged, compared to its average volume of 301. The company has a current ratio of 3.07, a quick ratio of 3.07 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $26.96 million, a P/E ratio of -20.06 and a beta of 0.18. The business has a 50 day moving average price of $34.45 and a two-hundred day moving average price of $34.95. AB Corporate Bond ETF has a 12 month low of $33.64 and a 12 month high of $36.63.

AB Corporate Bond ETF Cuts Dividend

The firm also recently announced a monthly dividend, which was paid on Friday, September 4th. Shareholders of record on Tuesday, September 1st were issued a dividend of $0.1284 per share. The ex-dividend date of this dividend was Tuesday, September 1st. This represents a $1.54 dividend on an annualized basis and a yield of 4.6%. This is a drop from AB Corporate Bond ETF’s previous monthly dividend of $0.1427. AB Corporate Bond ETF’s dividend payout ratio (DPR) is presently -101.79%.

AB Corporate Bond ETF Company Profile

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.